Sustained delivery formulations of octreotide compounds

Details for Australian Patent Application No. 2005316545 (hide)

Owner QLT USA, Inc.

Inventors Dadey, Eric; Downing, John Milton; Li, Ellen Qi; Dunn, Richard L.; Warren, Stephen L.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005316545

PCT Pub. Number WO2006/065951

Priority 60/636,273 15.12.04 US

Filing date 15 December 2005

Wipo publication date 22 June 2006

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

Event Publications

9 August 2007 PCT application entered the National Phase

  PCT publication WO2006/065951 Priority application(s): WO2006/065951

12 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005316551-Composition and methods for improved lubrication, pour point, and fuel performance

2005316540-Pyrid-2-ones useful as inhibitors of Tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases